MARKET

GNPX

GNPX

Genprex Inc
NASDAQ
0.7380
+0.0079
+1.08%
Closed 18:44 01/14 EST
OPEN
0.7514
PREV CLOSE
0.7301
HIGH
0.7680
LOW
0.7200
VOLUME
324.25K
TURNOVER
85.35K
52 WEEK HIGH
13.00
52 WEEK LOW
0.2806
MARKET CAP
6.28M
P/E (TTM)
-0.0620
1D
5D
1M
3M
1Y
5Y
1D
Genprex Advances Cancer Trials and Diabetes Therapy
TipRanks · 1d ago
Weekly Report: what happened at GNPX last week (0106-0110)?
Weekly Report · 1d ago
Weekly Report: what happened at GNPX last week (1230-0103)?
Weekly Report · 01/06 11:58
Weekly Report: what happened at GNPX last week (1223-1227)?
Weekly Report · 12/30/2024 11:50
Weekly Report: what happened at GNPX last week (1216-1220)?
Weekly Report · 12/23/2024 11:58
Biotech Alert: Searches spiking for these stocks today
TipRanks · 12/19/2024 17:01
Genprex receives Safety Review Committee approval to advance Acclaim-3 trial
TipRanks · 12/16/2024 14:20
GENPREX INC: RESULTS FROM PHASE 1 DOSE ESCALATION DEMONSTRATE FAVORABLE SAFETY PROFILE OF REQORSA AND TECENTRIQ IN ES-SCLC PATIENTS
Reuters · 12/16/2024 14:15
More
About GNPX
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Company’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid nanoparticles. The Company’s lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Using a different gene therapy delivery system, the Company is also developing its preclinical diabetes candidate GPX-002 using the same construct for both Type 1 diabetes and Type 2 diabetes. It conducts preclinical research to explore how REQORSA may be administered in other solid tumors.

Webull offers Genprex Inc stock information, including NASDAQ: GNPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNPX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNPX stock methods without spending real money on the virtual paper trading platform.